2. Academic Validation
  3. In-vitro activity of meropenem against Neisseria gonorrhoeae, Haemophilus influenzae and H. ducreyi from Canada and Kenya

In-vitro activity of meropenem against Neisseria gonorrhoeae, Haemophilus influenzae and H. ducreyi from Canada and Kenya

  • J Antimicrob Chemother. 1989 Sep;24 Suppl A:183-6. doi: 10.1093/jac/24.suppl_a.183.
L Slaney 1,  H Chubb,  Z Mohammed,  A Ronald
Affiliations

Affiliation

  • 1 Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
PMID: 2509415 DOI: 10.1093/jac/24.suppl_a.183
Abstract

Meropenem, a new parenteral carbapenem demonstrated increased activity as compared to imipenem against 336 strains of Neisseria gonorrhoeae, 119 strains of Haemophilus influenzae, and 110 strains of H. ducreyi. Neither carbapenem was affected by the Beta-lactamase activity of the organisms tested. Ceftriaxone and ciprofloxacin demonstrated activity superior to that of both carbapenems while the activity of ceftazidime was similar to that of meropenem.

Figures
Products